WIRE — JPNN.com - Perusahaan biofarmasi Takeda akan menginvestasikan dana hingga USD30 juta atau sekitar Rp 539 miliar untuk membangun ekosistem produk obat derivat plasma di Indonesia. Bank plasma pertama ditargetkan mulai beroperasi pada 2027.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.